Bioprox Healthcare has developed exclusive expertise in producing high-concentration probiotics with optimized stability.
Cutting-edge technical expertise and quality, driven by skilled human resources:
—
An experienced team of doctors, engineers and technicians specialized in development, production and optimization.
—
A dedicated QA & QC team providing quality support (e.g., analysis methods on Petri dishes, flow cytometry).
–
Partnerships with scientific network
(INRAe, CNRS, Pasteur Institute, etc.)
Advanced technologies
and tools
–
A molecular biology laboratory equipped state-of-the-art software and techniques
–
Access to specialized databases for enhanced strain identification and phenotype/genotype correlation
–
Use of high-level techniques to verify strain purity
Research and testing
under real-world conditions
–
In-depth understanding of the behaviour of our probiotic strain catalogue
• Genetic identification
• Virulence factors
• Survival in gastrointestinal conditions
• Probiotic mechanisms and health-related functions
• Stability over time
–
Development studies
tailored to your proprietary next-generation strains
Processes that match your needs
—
Optimization of fermentation parameters
—
Customized analytical solutions
—
Strain/matrix screening
—
Optimization of production and storage stability
Backed by over 40 years of expertise in industrial fermentation, our R&D department combines engineering excellence with cutting-edge equipment to develop manufacturing processes that achieve maximum yields at an industrial scale. These processes are designed for batch-to-batch consistency and uncompromising quality, ensuring reliable performance and reproducibility across every production run.
Interested?
Collaborations with the most demanding clients and partnerships with academic experts in freeze-drying, combined with ongoing technological and scientific monitoring, have driven Bioprox Healthcare to pursue the highest stability standards for its lyophilized probiotic powders.
We have the capability to identify, at the lab level, the most effective processes and technologies for industrial-scale production. Our R&D and manufacturing teams work closely together to transition your strains from cryotubes to the first industrial batch within just 4–6 months.
Looking for solutions or need support?
S.svg){kind=logo}